CL2012000271A1 - Compuestos derivados de metilpirrolo[3,2-d]pirimidincarboxamida, inhibidores de pde5; composición farmacéutica que los comprende; y uso en el tratamiento en enfermedades de las vías respiratorias, hipertensión portal, nefritis, cirrosis hepática, entre otras. - Google Patents

Compuestos derivados de metilpirrolo[3,2-d]pirimidincarboxamida, inhibidores de pde5; composición farmacéutica que los comprende; y uso en el tratamiento en enfermedades de las vías respiratorias, hipertensión portal, nefritis, cirrosis hepática, entre otras.

Info

Publication number
CL2012000271A1
CL2012000271A1 CL2012000271A CL2012000271A CL2012000271A1 CL 2012000271 A1 CL2012000271 A1 CL 2012000271A1 CL 2012000271 A CL2012000271 A CL 2012000271A CL 2012000271 A CL2012000271 A CL 2012000271A CL 2012000271 A1 CL2012000271 A1 CL 2012000271A1
Authority
CL
Chile
Prior art keywords
treatment
respiratory tract
pyrimidinecarboxamide
methylpyrrolo
nephritis
Prior art date
Application number
CL2012000271A
Other languages
English (en)
Inventor
Beate Schmidt
Josef Stadlwieser
Heiko Bernsmann
Torsten Dunkern
Ewald Benediktus
Andreas Pahl
Ragna Hussong
Olaf Nimz
Matthias Müller
Martin Viertelhaus
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41698276&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2012000271(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of CL2012000271A1 publication Critical patent/CL2012000271A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LA PRESENTE INVENCIÓN DESCRIBE COMPUESTOS DE FÓRMULA (1) LAS SALES FARMACÉUTICAS DE LOS MISMOS, Y LOS ESTEREOISÓMEROS DE LOS COMPUESTOS Y LAS SALES FARMACÉUTICAS DE LOS MISMOS EN DONDE RL, R2, R3, R21, R22, R23, R24 Y Y TIENEN LOS SIGNIFICADOS COMO SE INDICA EN LA MEMORIA DESCRIPTIVA Y PLIEGO DE REIVINDICACIONES; ADICIONALMENTE<br /> SE DESCRIBEN LAS COMPOSICIONES FARMACÉUTICAS QUE COMPRENDEN A DICHOS COMPUESTOS; Y AL USO DE LOS MISMOS EN LA PREPARACIÓN DE UN MEDICAMENTO ÚTIL EN EL TRATAMIENTO O PROFILAXIS DE UNA ENFERMEDAD AGUDA O CRÓNICA DE LAS VÍAS RESPIRATORIAS, ENTRE ELLAS HIPERTENSIÓN ARTERIAL PULMONAR, Y EL TRATAMIENTO O PROFILAXIS DE ENFERMEDAD ARTERIAL PERIFÉRICA, DÍABETES MELLITUS, SÍNDROME DE RAYNAUD, VEJIGA HIPERACTIVA, SÍNTOMAS DEL TRACTO URINARIO INFERIOR (LUTS), HIPERTENSION PORTAL, NEFRITIS, ENTRE OTRAS.  
CL2012000271A 2009-08-26 2012-02-01 Compuestos derivados de metilpirrolo[3,2-d]pirimidincarboxamida, inhibidores de pde5; composición farmacéutica que los comprende; y uso en el tratamiento en enfermedades de las vías respiratorias, hipertensión portal, nefritis, cirrosis hepática, entre otras. CL2012000271A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP09168685 2009-08-26

Publications (1)

Publication Number Publication Date
CL2012000271A1 true CL2012000271A1 (es) 2012-08-31

Family

ID=41698276

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2012000271A CL2012000271A1 (es) 2009-08-26 2012-02-01 Compuestos derivados de metilpirrolo[3,2-d]pirimidincarboxamida, inhibidores de pde5; composición farmacéutica que los comprende; y uso en el tratamiento en enfermedades de las vías respiratorias, hipertensión portal, nefritis, cirrosis hepática, entre otras.

Country Status (26)

Country Link
US (2) US8927557B2 (es)
EP (1) EP2470536B1 (es)
JP (1) JP5791606B2 (es)
KR (1) KR101762884B1 (es)
CN (1) CN102574861B (es)
AR (1) AR077898A1 (es)
AU (1) AU2010288550B2 (es)
BR (1) BR112012003616A8 (es)
CA (1) CA2771938A1 (es)
CL (1) CL2012000271A1 (es)
CO (1) CO6491110A2 (es)
EA (1) EA021103B1 (es)
EC (1) ECSP12011678A (es)
ES (1) ES2529563T3 (es)
HK (1) HK1169411A1 (es)
IL (1) IL218126A (es)
MX (1) MX2012002432A (es)
MY (1) MY159031A (es)
NZ (1) NZ598777A (es)
PE (1) PE20121133A1 (es)
SG (1) SG178481A1 (es)
TN (1) TN2012000034A1 (es)
TW (1) TWI471327B (es)
UA (1) UA106628C2 (es)
WO (1) WO2011023693A1 (es)
ZA (1) ZA201200616B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102010021637A1 (de) 2010-05-26 2011-12-01 Bayer Schering Pharma Aktiengesellschaft Substituierte 5-Fluor-1H-Pyrazolopyridine und ihre Verwendung
MX2013014888A (es) * 2011-06-17 2014-02-27 Takeda Gmbh Novedosos derivados de ftalazinona-pirrolopirimidinacarboxamida.
MX2015010725A (es) 2013-02-21 2016-05-31 Adverio Pharma Gmbh Formas de metil {4,6-diamino-2-[1-(2-fluorobencil)-1h-pirazolo [3,4-b] piridino-3-il] pirimidino-5-il} metil carbamato.
JP2020097527A (ja) * 2017-03-31 2020-06-25 武田薬品工業株式会社 複素環化合物
CN107286160A (zh) * 2017-06-05 2017-10-24 毛佳婧 一种抗肝炎药物的哌啶并吡啶并吡唑‑锌配合物的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2754260B1 (fr) 1996-10-04 1998-10-30 Adir Nouveaux derives substitues de biphenyle ou de phenylpyridine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US6187777B1 (en) * 1998-02-06 2001-02-13 Amgen Inc. Compounds and methods which modulate feeding behavior and related diseases
EP1286997B1 (en) * 2000-06-07 2004-08-18 Almirall Prodesfarma, S.A. 6-phenylpyrrolopyrimidinedione derivatives
CA2433778A1 (en) 2001-02-14 2002-08-22 William Glen Harter Thieno'2,3-d pyrimidindione derivatives as matrix metalloproteinase inhibitors
CN100374441C (zh) * 2003-06-06 2008-03-12 天津倍方科技发展有限公司 二氢吡咯[2，3-d]嘧啶-4-酮衍生物，其制备方法及其制药用途
US20050124623A1 (en) * 2003-11-26 2005-06-09 Bender John A. Diazaindole-dicarbonyl-piperazinyl antiviral agents
PL1807072T3 (pl) 2004-10-29 2009-06-30 Lilly Co Eli Cykloalkilowe pochodne laktamów jako inhibitory 11-ß-HSD1
CA2599368A1 (en) * 2005-03-09 2006-09-14 Nycomed Gmbh Amido-substituted 6-phenylphenanthridines
SI2057165T1 (sl) 2006-09-07 2011-07-29 Ind Res Ltd Gracefield Res Ct Acikliäśni aminski zaviralci nukleozidnih fosforilaz in hidrolaz
JP4837701B2 (ja) * 2007-04-20 2011-12-14 田辺三菱製薬株式会社 医薬組成物
AR070454A1 (es) * 2008-02-27 2010-04-07 Nycomed Gmbh Pirrolopirimidincarboxamidas y composiciones farmaceuticas que las comprenden

Also Published As

Publication number Publication date
MX2012002432A (es) 2012-04-11
UA106628C2 (uk) 2014-09-25
US20120149721A1 (en) 2012-06-14
EA201200322A1 (ru) 2012-09-28
CN102574861B (zh) 2015-08-05
NZ598777A (en) 2013-10-25
EP2470536B1 (en) 2014-11-12
JP2013503131A (ja) 2013-01-31
ZA201200616B (en) 2012-10-31
CO6491110A2 (es) 2012-07-31
IL218126A0 (en) 2012-06-28
MY159031A (en) 2016-12-15
BR112012003616A8 (pt) 2018-02-06
ES2529563T3 (es) 2015-02-23
IL218126A (en) 2015-08-31
TWI471327B (zh) 2015-02-01
AU2010288550B2 (en) 2015-01-29
PE20121133A1 (es) 2012-08-30
US9376442B2 (en) 2016-06-28
US8927557B2 (en) 2015-01-06
KR101762884B1 (ko) 2017-07-28
AR077898A1 (es) 2011-09-28
CA2771938A1 (en) 2011-03-03
ECSP12011678A (es) 2012-03-30
HK1169411A1 (zh) 2013-01-25
AU2010288550A1 (en) 2012-04-12
SG178481A1 (en) 2012-03-29
TW201111384A (en) 2011-04-01
JP5791606B2 (ja) 2015-10-07
CN102574861A (zh) 2012-07-11
KR20120107458A (ko) 2012-10-02
WO2011023693A1 (en) 2011-03-03
EP2470536A1 (en) 2012-07-04
BR112012003616A2 (pt) 2016-02-23
EA021103B1 (ru) 2015-04-30
US20150073001A1 (en) 2015-03-12
TN2012000034A1 (en) 2013-09-19

Similar Documents

Publication Publication Date Title
UY30312A1 (es) Derivados de n-(2-tiazolil)-amida como inhibidores de gsk-3
AR112074A2 (es) Derivados de 2-carboxamida-cicloamino-urea como inhibidores de pi-3
ECSP10010556A (es) Piridinas y pirazinas como inhibidores de pi3k
BR112015018751A2 (pt) derivados de piridazinona macrocíclicos
ECSP11010948A (es) Inhibidores de las enzimas de proteína cinasa activadas por
ECSP11011371A (es) Inhibidor de la map cinasa p38
GT200600134A (es) Compuestos novedosos de derivados de aminosulfonilo
CL2012000271A1 (es) Compuestos derivados de metilpirrolo[3,2-d]pirimidincarboxamida, inhibidores de pde5; composición farmacéutica que los comprende; y uso en el tratamiento en enfermedades de las vías respiratorias, hipertensión portal, nefritis, cirrosis hepática, entre otras.
DOP2011000204A (es) Inhibidores de proteina cinasa
UY28756A1 (es) Compuestos
CU20110129A7 (es) Piridiloxi-indoles inhibidores del vegf-r2 y uso de los mismos para el tratamiento de enfermedades
DOP2006000169A (es) Inhibidores espiropiperidina de beta-secretasa para el tratamiento de la enfermedad de alzheimer
BR122013025375B8 (pt) compostos orgânicos, seus métodos de preparo e uso, bem como composições farmacêuticas
MX2009002239A (es) Derivados de 5-(2-furil)-1,3-tiazol util como inhibidores de fosfatidilinositol 3-cinasa.
CL2011001082A1 (es) Compuestos derivados de amino-tetrahidropiranos sustituidos con heterociclos, composicion farmaceutica; y uso en el tratamiento de una afeccion seleccionada de resistencia a la insulina, hiperglicemia y diabetes de tipo 2.
WO2008030412A3 (en) Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer&#39;s disease
UY28755A1 (es) Compuestos
EA200801996A1 (ru) 2-замещенные производные 4-бензилфталазинонов в качестве гистаминовых h1- и h3-антагонистов
CR9881A (es) Polimorfos de la sal benzoato de 2-[[6-[(3r)-3amino-1-piperidinil]-3,4-dihidro-3-metil-2,4-dioxo-1(2h)-pirimidinil]metil]-benzonitrilo y metodos de uso para los mismos
GT200800242A (es) Derivados biciclicos como inhibidores de cetp
UY31431A1 (es) Inhibidor de la proteina activadora de la 5-lipoxigenasa (flap)
CR11208A (es) Derivados de pirimidina utiles para el tratamiento de condiciones inflamatorias o alergicas
EA201200918A1 (ru) Производные пирролидин карбоновой кислоты как агонисты сопряженного с g-белком рецептора 43 (gpr43), фармацевтическая композиция и методы их использования при лечении метаболических нарушений
BR112012015967A2 (pt) uso de compostos de fórmula geral (i) e composição farmacêutica
EA200870302A1 (ru) 1,3-диоксанкарбоновые кислоты